A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  New England Journal of Medicine

• Publication date

  1996-02-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199602083340602PMID 8538705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

  1996cited by this paper
• Acellular pertussis vaccines--a question of efficacy.

  1995cited by this paper
• Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.

  1995cited by this paper
• A placebo-controlled trial of a pertussis-toxoid vaccine.

  1995cited by this paper
• The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data.

  1995cited by this paper
• Comparison of five calculation modes for antibody ELISA procedures using pertussis serology as a model.

  1995cited by this paper
• Comparison of 13 acellular pertussis vaccines: overview and serologic response.

  1995cited by this paper
• Comparison of nasopharyngeal aspirates with swabs for culture of Bordetella pertussis

  1993cited by this paper
• Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica.

  1993cited by this paper
• Comparison of 13 acellular pertussis vaccines: adverse reactions.

  1993cited by this paper
• Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15- to 24-month-old children.

  1992cited by this paper
• Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance.

  1992cited by this paper
• Controlled study of a new five-component acellular pertussis vaccine in adults and young children.

  1992cited by this paper
• Pertussis: the trials and tribulations of old and new pertussis vaccines.

  1992cited by this paper
• Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. The APDT Vaccine Study Group.

  1991cited by this paper
• Differences in antibody response to whole-cell pertussis vaccines.

  1991cited by this paper
• Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants

  1991cited by this paper
• Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial.

  1991cited by this paper
• Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis

  1990cited by this paper
• Haemophilus influenzae infections and whooping cough.

  1990cited by this paper
• Report of the Committee on Infectious Diseases

  1989cited by this paper
• Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants.

  1988cited by this paper
• Report of the Task Force on Pertussis and Pertussis Immunization—1988

  1988cited by this paper
• Mortality and morbidity from invasive bacterial infections during a clinical trial of acellular pertussis vaccines in Sweden.

  1988cited by this paper
• Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists.

  1987cited by this paper
• Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children.

  1981cited by this paper
• The Statistical Analysis of Failure Time Data

  1980cited by this paper
• Enrichment medium for the isolation of Bordetella

  1977cited by this paper
• STEATORRHŒA IN ADDISON'S DISEASE

  1963cited by this paper

• SeaB is a conserved Salmonella enterica extracellular matrix binding protein involved in biofilm formation and infection

  2026cites this paper
• Comparative analysis of the diversity within the B. bronchiseptica fimX locus.

  2026cites this paper
• Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel

  2025cites this paper
• Variation in virulence between three representative Bordetella pertussis pertactin-negative clinical isolates

  2025cites this paper
• Global variations in immunisation strategies against pertussis in infancy

  2025cites this paper
• Adenoviral-vectored vaccine against Bordetella pertussis fimbrial antigens induce partial protection in a mouse model

  2025cites this paper
• Resurgence of pertussis: whopping the ‘100-day cough’

  2025cites this paper
• Respiratory immunization using antibiotic-inactivated Bordetella pertussis confers T cell-mediated protection against nasal infection in mice

  2025cites this paper
• The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?

  2025cites this paper
• Diphtheria immunogenicity following the administration of pentavalent DTwP-HB-Hib vaccine at 4- and 8-week intervals: A randomized controlled trial

  2025cites this paper
• What's Old is New Again: Pertussis.

  2025cites this paper
• Safety assessments of recombinant DTaP vaccines developed in South Korea

  2024cites this paper
• High pertussis circulation among infants, children and adolescents in Abidjan, Côte d’Ivoire

  2024cites this paper
• Current Progress in the Development of mRNA Vaccines Against Bacterial Infections

  2024cites this paper
• IDENTIFYING PLAUSIBLE RANGES FOR DIFFERENTIAL VACCINE EFFICACY ACROSS HIGH- AND LOW-INCOME SETTINGS: A SYSTEMATIC REVIEW, DESCRIPTIVE META-ANALYSIS, AND ILLUSTRATIVE EVIDENCE ANALYSIS

  2024cites this paper
• The contributions of T cell-mediated immunity to protection from vaccine-preventable diseases: A primer

  2024cites this paper
• Bibliometrics analysis and knowledge mapping of pertussis vaccine research: trends from 1994 to 2023

  2024influential citation
• Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections

  2024cites this paper
• Use of Mucosally Administered Outer Membrane Vesicles Derived from Bordetella pertussis to Diminish Nasal Bacterial Colonization

  2024cites this paper
• Mucosal vaccination with outer membrane vesicles derived from Bordetella pertussis reduces nasal bacterial colonization after experimental infection

  2024cites this paper
• Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial

  2024cites this paper
• A whole-cell pertussis vaccine engineered to elicit reduced reactogenicity protects baboons against pertussis challenge

  2024cites this paper
• Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: a randomised, double-blind, non-inferiority trial

  2023cites this paper
• Antibody and B-cell immune responses against Bordetella pertussis following infection and immunization.

  2023cites this paper
• Evaluation of the effectiveness of maternal immunization against pertussis in Alberta using agent-based modeling: A Canadian immunization research network study.

  2023cites this paper
• Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study

  2023cites this paper
• A semi high-throughput whole blood-based flow cytometry assay to detect and monitor Bordetella pertussis-specific Th1, Th2 and Th17 responses

  2023cites this paper
• "Repeated B. pertussis Infections are Required to Reprogram Acellular Pertussis Vaccine-primed Host Responses in the Baboon Model".

  2023cites this paper
• Coping Strategies for Pertussis Resurgence

  2023cites this paper
• A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

  2023cites this paper
• Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India

  2022cites this paper
• Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination

  2022cites this paper
• "Antigen Discovery for Next-Generation Pertussis Vaccines using Immunoproteomics and Transposon Directed Insertion Sequencing".

  2022cites this paper
• A review of the DTaP-IPV-HB-PRP-T Hexavalent vaccine in pediatric patients

  2022influential citation
• Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy

  2022cites this paper
• Lack of association between febrile seizures and vaccines containing diphtheria, tetanus, and acellular pertussis in Chinese children

  2022cites this paper
• Antibodies binding diverse pertactin epitopes protect mice from Bordetella pertussis infection

  2022cites this paper
• Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model

  2021cites this paper
• Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis

  2021cites this paper
• Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

  2021cites this paper
• Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis

  2021cites this paper
• IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils

  2021cites this paper
• Is there a potential for novel, nasal pertussis vaccines?

  2021cites this paper
• Evaluation of B-Cell Kinetics After Acellular Pertussis Vaccination in Four Cohorts of Different Age and Priming Background

  2021cites this paper
• Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.

  2021cites this paper
• Whole-Cell Vaccine Preparation: Options and Perspectives.

  2021cites this paper
• Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children.

  2021cites this paper
• Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.

  2021cites this paper
• Modeling the waning and boosting of immunity from infection or vaccination

  2020cites this paper
• Comparison of Two Different Methods for the Extraction of Outer Membrane Vesicles from the Bordetella pertussis as a Vaccine Candidate.

  2020cites this paper
• Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination

  2020cites this paper
• Causes Of Pertussis Incidence Increase

  2020cites this paper
• Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries

  2020cites this paper
• A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: A Canadian Immunization Research Network Study.

  2020cites this paper
• Evaluation of immunisation strategies for pertussis vaccines in Jinan, China – an interrupted time-series study

  2020cites this paper
• Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting

  2020cites this paper
• OPTIMUM study protocol: an adaptive randomised controlled trial of a mixed whole-cell/acellular pertussis vaccine schedule

  2020cites this paper
• Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014.

  2020cites this paper
• Transversal sero-epidemiological study of Bordetella pertussis in Tehran, Iran

  2020cites this paper
• Acellular Pertussis Vaccine Components: Today and Tomorrow

  2020cites this paper
• Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.

  2020cites this paper
• Immuno-proteomics analysis between OMV of vaccine and dominant wild type strains of Bordetella pertussis in Iran

  2020cites this paper
• Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract

  2020cites this paper
• Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains

  2020cites this paper
• A Dissolvable Microneedle Formulation of Bordetella pertussis Subunit Vaccine: Translational Development and Immunological Evaluation in Mice.

  2019cites this paper
• Human Immune Responses to Pertussis Vaccines.

  2019cites this paper
• Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli

  2019influential citation
• Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines

  2019cites this paper
• Toward a Controlled Human Infection Model of Pertussis.

  2019cites this paper
• Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination.

  2019cites this paper
• Pertussis Vaccines and Vaccination Strategies. An Ever-Challenging Health Problem.

  2019cites this paper
• Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine

  2019cites this paper
• Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines

  2019cites this paper
• Further investigations of the IgE response to tetanus and diphtheria following covaccination with acellular rather than cellular Bordetella pertussis

  2019cites this paper
• The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future.

  2019cites this paper
• Bordetella pertussis in a four‐time kidney transplant recipient: A call for immunization programs at transplant centers

  2019cites this paper
• Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood

  2019cites this paper
• Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis

  2019influential citation
• National Outbreak of Pertussis in England, 2011-2012: A Case-control Study Comparing 3-Component and 5-Component Acellular Vaccines With Whole-cell Pertussis Vaccines.

  2019cites this paper
• Molecular detection and epidemiological studies of atypical bacteria causing respiratory tract infections

  2019cites this paper
• Pertussis vaccines and protective immunity.

  2019cites this paper
• Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.

  2019cites this paper
• Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness

  2018cites this paper
• Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells

  2018cites this paper
• Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance

  2018cites this paper
• Оценка стабильности производства коклюшного компонента АКДС-вакцины по показателям иммуногенной активности и специфической безопасности с использованием карт Шухарта

  2018cites this paper
• Prevention of pertussis: An unresolved problem

  2018cites this paper
• Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development

  2018cites this paper
• Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

  2018cites this paper
• Randomized Controlled Trial of the Safety and Immunogenicity of Revaccination With Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) in Adults 10 Years After a Previous Dose

  2018influential citation
• 19 – Diphtheria Toxoid

  2018cites this paper
• Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor

  2018cites this paper
• Prevention of pertussis: from clinical trials to Real World Evidence

  2018cites this paper
• Estimation of Consistency of Production of the Pertussis Component of DTP Vaccine in Terms of Immunogenic Activity and Specific Safety Using Shewhart Charts

  2018cites this paper
• 66 – Technologies for Making New Vaccines

  2018cites this paper
• 44 – Pertussis Vaccines

  2018cites this paper
• 15 – Combination Vaccines

  2018cites this paper
• A Critical Evaluation of Whole Cell Pertussis Vaccines on their Composition and Efficacy in Comparison to Acellular Pertussis Vaccines

  2017cites this paper
• Immune persistence after pertussis vaccination

  2017cites this paper
• An update of the global burden of pertussis in children younger than 5 years: a modelling study.

  2017cites this paper